You are viewing archived content
Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Table TDI-36. Primary amphetamine use among new clients entering treatment (%), 2005 to 2010
| Country | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | |
|---|---|---|---|---|---|---|---|
| Belgium | (1) | : | : | : | : | 12 | 13.1 |
| Bulgaria | 1.8 | 2.7 | 2 | 6.5 | 3.5 | 1 | |
| Czech Republic | 59.7 | 61.7 | 63.6 | 62.7 | 63.1 | 67.8 | |
| Denmark | 10.2 | 14.9 | 13.5 | 14.2 | 12.2 | 11.5 | |
| Germany | 9.7 | 10 | 10.4 | 10.6 | 10.3 | 12.6 | |
| Estonia | : | : | : | 4.5 | 6.4 | 10.8 | |
| Ireland | 1.1 | 0.9 | 1 | 1 | 0.6 | 0.9 | |
| Greece | 0 | 0 | 0 | 0.1 | 0 | 0.1 | |
| Spain | 1.1 | 1.2 | 1.2 | 1 | 1.2 | : | |
| France | 0.2 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | |
| Italy | (2) | 0.1 | 0.2 | 0.1 | 0.3 | 0.1 | 0.2 |
| Cyprus | 0.5 | 0 | 0 | 0 | 0.3 | 0.9 | |
| Latvia | (3) | 22.6 | 22.3 | 24 | 24.5 | 29 | 29.6 |
| Lithuania | 4.9 | 4.3 | 6.6 | 4.8 | 4.3 | 2.7 | |
| Luxembourg | 0.4 | 0.6 | 0.3 | 0.3 | 0.3 | 0.4 | |
| Hungary | 5.6 | 5.3 | 10.2 | 9.8 | 9.7 | 9.8 | |
| Malta | 0 | 0 | : | : | 0 | 0 | |
| Netherlands | 7 | 7.5 | 6.9 | 7.1 | 6.1 | 6.2 | |
| Austria | : | 2.5 | 2.8 | 1.8 | 2.5 | 2.9 | |
| Poland | (4) | : | : | : | 26.1 | 24.7 | : |
| Portugal | (5) | 0 | 0.2 | 0.1 | 0 | 0 | 0.2 |
| Romania | 0.2 | 0.5 | 0.2 | 0.3 | 0.3 | 1.5 | |
| Slovenia | 0.6 | 0.3 | 0 | 0 | 0.8 | 0.4 | |
| Slovakia | 30.1 | 32.2 | 33.2 | 39.1 | 34.6 | 41 | |
| Finland | 27.6 | 22 | 22.9 | 24.4 | 18.8 | 12.3 | |
| Sweden | 32.7 | 33 | 27.7 | 24.8 | 18.1 | 19.2 | |
| United Kingdom | (6) | 4.1 | 3.9 | 4.5 | 4.4 | 3.8 | 3.3 |
| Croatia | : | 0 | 7 | 2 | 3.3 | 1.9 | |
| Turkey | 0.1 | 0 | 0 | 0.1 | 0 | 0 | |
| Norway | : | : | : | : | : | : |
Notes:
: Indicates no data are available
Percentages are of new clients with known primary drug.
Only countries with available data are shown
(1) In Belgium if the exact primary drug is not known, the generic category is recorded. In 2010 there were 294 Opiates, 8 Cocaine, 7 Stimulants, 3 Hypnotics and Sedatives and 1 Hallucinogens clients with the primary exact drug unknown. Of which 27, 1 and 5 were new clients for respectively Opiates, Cocaine and Stimulants.
(2) In 2010 around 29% of all clients and 30% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.
Data are from 2009. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.
(3) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. 2010 data in this table are still methodologically in line with the data from previous years.
(4) Data are from 2009. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.
(5) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 data with previous years.
(6) Data are from 1st of April 2009 to 31st March 2010.
See also ‘General notes for interpreting data’ on the Explanatory notes and help page.
Sources:
Reitox national reports 2011 — Standard table 34 See also Table TDI-4 and Table TDI-5 and see Table TDI-0] for details on sources.